by Eric Christianson | Aug 12, 2026 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Finerenone (Kerendia) is a relatively newer medication for the management of chronic kidney disease (CKD) in patients with type 2 diabetes and heart failure with preserved ejection fraction. In addition to these indications, there was a recent study that showed...
by Eric Christianson | Feb 5, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
This video is part of a three-part series covering new literature that could influence clinical practice. Finerenone has been studied in the setting of HFpEF and I review this topic. More specifically, in this video, I discuss the background of why finerenone may be...
by Eric Christianson | Jan 8, 2023 | Clinical Guideline Updates For Pharmacists
The ADA has released its 2023 guidelines. There are a significant number of impacts on medication therapy, and in this post I will outline my most important takeaways. I was also recently catching up with my friend and fellow pharmacist, Derek Borkowski who is the...
by Eric Christianson | Jan 12, 2022 | Clinical Guideline Updates For Pharmacists
The American Diabetes Association released their 2022 Diabetes Guidelines update. While I wouldn’t call the changes earth-shattering, there are some items in relation to pharmacotherapy that I feel are really important to note. The patient population that I work...
